SPRTN and neuroblastoma: Gene expression analysis in non-MYCN-amplified NB tumors showed that higher expression levels of SPRTN, FH, EXO1, and SMYD3 were associated with worse overall survival in both the Versteeg and SEQC cohorts, where only EXO1 displayed Bonferroni-corrected statistical significance in both.